| A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome T Snowsill, N Huxley, M Hoyle, T Jones-Hughes, H Coelho, C Cooper, ... NIHR Health technology Assessment Programme, 2014 | 132 | 2014 |
| Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation T Snowsill, H Coelho, N Huxley, T Jones-Hughes, S Briscoe, IM Frayling, ... Health technology assessment 21 (51), 1-280, 2017 | 108 | 2017 |
| Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model T Jones-Hughes, T Snowsill, M Haasova, H Coelho, L Crathorne, ... Health Technology Assessment 20 (62), 2016 | 63 | 2016 |
| A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients T Snowsill, N Huxley, M Hoyle, T Jones-Hughes, H Coelho, C Cooper, ... BMC cancer 15 (1), 1-10, 2015 | 46 | 2015 |
| A systematic review and economic evaluation of intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer N Huxley, T Jones-Hughes, H Coelho, T Snowsill, C Cooper, Y Meng, ... Health Technology Assessment 19 (2), 1-216, 2015 | 37* | 2015 |
| The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for … N Huxley, L Crathorne, J Varley-Campbell, I Tikhonova, T Snowsill, ... Health Technology Assessment 21 (38), V-241, 2017 | 33 | 2017 |
| The predicted impact and cost‐effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome YJ Kang, J Killen, M Caruana, K Simms, N Taylor, IM Frayling, T Snowsill, ... Medical Journal of Australia 212 (2), 72-81, 2020 | 29 | 2020 |
| Economic analysis of first-line treatment with cetuximab or panitumumab for RAS wild-type metastatic colorectal cancer in England IA Tikhonova, N Huxley, T Snowsill, L Crathorne, J Varley-Campbell, ... PharmacoEconomics 36 (7), 837-851, 2018 | 25 | 2018 |
| Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation TM Snowsill, J Moore, RE Mujica Mota, JL Peters, TL Jones-Hughes, ... Nephrology Dialysis Transplantation 32 (7), 1251-1259, 2017 | 23 | 2017 |
| The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer-treatment induced anaemia (including review of TA142 … L Crathorne, N Huxley, M Haasova, T Snowsill, T Jones-Hughes, M Hoyle, ... NIHR Health Technology Assessment Programme, 2016 | 21 | 2016 |
| A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome H Coelho, T Jones-Hughes, T Snowsill, S Briscoe, N Huxley, IM Frayling, ... BMC cancer 17 (1), 1-13, 2017 | 15 | 2017 |
| Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation. M Haasova, T Snowsill, T Jones-Hughes, L Crathorne, C Cooper, ... Health technology assessment (Winchester, England) 20 (61), 1, 2016 | 14 | 2016 |
| Cost Effectiveness of Cetuximab and Panitumumab for First-Line RAS WT Metastatic Colorecal Cancer I Tikhonova, M Hoyle, T Snowsill, L Crathorne, J Varley-Campbell, ... Value in Health 19 (3), A154, 2016 | 3 | 2016 |
| Model-Based Cost–Utility Analysis of Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Treatment Induced Anaemia in the UK NHS T Snowsill, N Huxley, M Hoyle, L Crathorne, M Haasova, S Briscoe, ... Value in Health 17 (7), A641-A642, 2014 | 2 | 2014 |
| Immunosuppressive therapy for kidney transplantation in adults (review of technology appraisal guidance 85): A systematic review and economic model T Jones-Hughes, T Snowsill, M Haasova, H Coelho, L Crathorne, ... University of Exeter, 2015 | 1 | 2015 |
| Provider behaviour and quality of care in prostate cancer NJ HUXLEY Monash University, 2021 | | 2021 |
| Immunosuppressive agents in adult kidney transplantation in the NHS: a model-based economic evaluation TM Snowsill, J Moore, R Mujica Mota, JL Peters, T Jones-Hughes, ... Oxford University Press (OUP) for European Renal Association-European …, 2017 | | 2017 |
| The clinical and cost-effectiveness of lenalidomide for people who have received at least one prior therapy with bortezomib (partial review of TA171): A critique of the … N Huxley, L Long, S Briscoe, M Hoyle University of Exeter, 2016 | | 2016 |
| A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients C Hyde, I Frayling, C Cooper, H Coelho, T Jones-Hughes, M Hoyle, ... | | 2015 |
| Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer [ID794]: Multiple Technology Appraisal (MTA) N Huxley, L Crathorne, J Varley-Campbell, I Tikhonova, T Snowsill, ... University of Exeter, 2015 | | 2015 |
